[ad_1] Research shows that sixty to eighty percent of population health outcomes are driven by non-clinical factors, mainly social determinants of health (SDoH). SDoH includes the environmental factors that affect…
Tag: medical devices
Why Provider Groups Are Denouncing CMS’ New Payment Rules – MedCity News
[ad_1] This week, the Centers for Medicare & Medicaid Services finalized updates to its physician fee schedule for 2024, as well as finalized the rule for next year’s Outpatient Prospective…
Unlocking the Power of Healthcare Audiences: Segmenting Stakeholders and Maximizing Impact – MedCity News
[ad_1] In today’s rapidly evolving healthcare landscape, developing strong core brand strategies is crucial for successful marketing campaigns within the healthcare and med-tech industries. The diverse group of stakeholders that…
Revamping HHS’ Complex Organizational Structure Could Improve Its Performance During Public Health Emergencies – MedCity News
[ad_1] “We shape our buildings,” Winston Churchill once said, “and afterwards our buildings shape us.” The same could be said of an organization’s structure and its ongoing impact on members…
How KelaHealth Slashed the Rate of Post-Surgical Complications at Duke – MedCity News
[ad_1] The digital health market is full of companies promising to transform healthcare, but investors and health systems are finally demanding to see evidence from startups that actually prove their tech’s…
Why Physicians in ACOs Are Happier With Their Compensation – MedCity News
[ad_1] Only 21% of primary care physicians feel they are fairly compensated, according to a new report released by Pearl Health, a tech company that helps independent physician practices participate…
BeMe Health Partners With 2 Health Plans To Support Teen Mental Health – MedCity News
[ad_1] BeMe Health, a digital mental health company for teens, is working with Inland Empire Health Plan and Molina Healthcare of California to bring its services to teens in schools…
Genentech Veteran Named New BioMarin CEO as Gene Therapy Launch Ramps Up – MedCity News
[ad_1] Jean-Jacques Bienaimé, who over the course of nearly two decades grew BioMarin Pharmaceutical’s portfolio from a single commercialized asset to multiple marketed products—including a landmark approval in gene therapy—is…